Find clinical trials for Diabetes in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus

Type 2 Diabetes Mellitus

Type 1 Diabetes Mellitus

Diabetic Foot

Foot Ulcer

Ulcer

Obesity

Diabetes trials near Berlin, BE, DEU:

Combined Active Treatment in Type 2 Diabetes with NASH (COMBAT_T2_NASH)

type 2 diabetes....

Active, not recruiting

Type 2 Diabetes

Non-alcoholic Steatohepatitis (NASH)

Drug: Empagliflozin 10mg oral tablet / Semaglutide 1mg pen injector

Drug: Placebo matching empagliflozin and placebo pen injector matching semaglutide

Phase 4

German Diabetes Center

Berlin, Germany and 25 other locations

A Phase III Study to Investigate If the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed with Type 1 Diabetes (DIAGNODE-3)

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Enrolling

Type 1 Diabetes Mellitus

Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®

Biological: Placebo

Phase 3

Diamyd Medical

Berlin, Germany and 59 other locations

Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus Global (ABILITY)

To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and safe...

Active, not recruiting

Diabetes

Coronary Artery Disease

Device: XIENCE Everolimus Eluting Coronary Stent System (XIENCE family)

Device: Abluminus DES+ Sirolimus Eluting Stent System (SES)

Concept Medical

Berlin, Germany and 89 other locations

Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...

Active, not recruiting

Diabetic Cardiomyopathies

Drug: AT-001

Drug: Placebo

Phase 3

Applied Therapeutics

Berlin, Germany and 78 other locations

A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CVOT)

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...

Active, not recruiting

Type 2 Diabetes Mellitus

Drug: Tirzepatide

Drug: Dulaglutide

Phase 3

Lilly

Berlin, Germany and 652 other locations

Locations recently updated

Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus. (SOLSTICE)

double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...

Enrolling

Diabetes Mellitus, Type 2

Drug: AZD5004

Drug: Placebo (placebo matching AZD5004 film-coated tablet)

Phase 2

AstraZeneca

Falkensee, Germany and 103 other locations

A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test Its Effect in People Living With Excess Body Weight With or Without Type 2 Diabetes

A new study medicine called NNC0519-0130 to improve treatment options for people living with excess body weight, with or without type 2 diabetes...

Enrolling

Diabetes Mellitus, Type 2

Obesity

Drug: NNC0519-0130

Drug: Placebo

Phase 1

Novo Nordisk

Berlin, Germany

Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus

at Week 52 in participants with overweight or obesity without diabetes mellitus (Cohort A) and in participants with overweight or obesity wi...

Active, not recruiting

Type 2 Diabetes Mellitus

Overweight

Drug: Placebo

Biological: Maridebart Cafraglutide

Phase 2

Amgen

Berlin, Germany and 78 other locations

A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes (CONFIDENCE)

Finerenone works by blocking a group of proteins, called mineralocorticoid receptor. An increased stimulation of mineralocorticoid receptor is known...

Active, not recruiting

Type 2 Diabetes Mellitus

Chronic Kidney Disease

Drug: Finerenone (BAY94-8862 ) 20 mg

Drug: Finerenone Placebo

Phase 2

Bayer

Berlin, Germany and 188 other locations

Remote And Decentralised Innovative Approaches to Clinical Trials (RADIAL)

study comparing Decentralised Clinical Trial (DCT) and hybrid approaches to conventional clinical trial approaches in patients with Type 2 diabetes...

Active, not recruiting

Diabetes Mellitus, Type 2

Other: Methodological intervention

Drug: Toujeo

Phase 4

Mira Zuidgeest

Berlin, Germany and 8 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Diabetes in .css-epvm6{white-space:nowrap;}Berlin, BE

Related conditions:

Diabetes trials near Berlin, BE, DEU:

Combined Active Treatment in Type 2 Diabetes with NASH (COMBAT_T2_NASH)

A Phase III Study to Investigate If the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed with Type 1 Diabetes (DIAGNODE-3)

Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus Global (ABILITY)

Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy

A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CVOT)

Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus. (SOLSTICE)

A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test Its Effect in People Living With Excess Body Weight With or Without Type 2 Diabetes

Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus

A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes (CONFIDENCE)

Remote And Decentralised Innovative Approaches to Clinical Trials (RADIAL)

Find clinical trials for Diabetes in Berlin, BE